Endpoints News· @endpts · X·· 4 小时前AI 评分42
AI 导读
独家：Rudy Tanzi 的 Acta Pharmaceuticals 正式启动，融资 2400 万美元，用于测试一款他称之为“阿尔茨海默病他汀”的口服药。https://endpoints.news/rudy-tanzi-has-long-wanted-to-prevent-alzheimers-he-may-be-close/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
正文
Exclusive: Rudy Tanzi’s Acta Pharmaceuticals launches with $24M to test a pill he says will be “the statin of Alzheimer’s disease.” https://endpoints.news/rudy-tanzi-has-long-wanted-to-prevent-alzheimers-he-may-be-close/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源：Endpoints News · x.com